Company insight
Catheter innovation for pulsed field ablation
Phillips Medisize, together with its parent company Molex, brings over 60 years of experience in contract development and manufacturing, providing medical device companies with the integrated capabilities necessary to help design, develop and deliver life-enhancing and life-saving products.
I
n a rapidly evolving healthcare landscape, cardiovascular care sits at the crossroads of groundbreaking innovation and complex challenges. From advanced catheter designs to the integration of digital technologies, the industry continuously adapts to improve patient outcomes and redefine minimally invasive treatments. As the global incidence of cardiovascular disease rises, so does the demand for catheter solutions that combine reliability with cutting-edge functionality. Meeting these demands requires a comprehensive approach blending engineering expertise, advanced manufacturing and electronic innovation.
Connectivity transformation Connectivity innovation is reshaping cardiovascular catheters. The integration of miniaturised sensors and electronics enables real-time physiological monitoring during procedures, giving clinicians actionable data to improve precision and outcomes.
Phillips Medisize is helping to pioneer the assembly and manufacturing of these sophisticated devices, including the integration of optical fibre for sensing applications. Optical fibres facilitate advanced diagnostics and real-time feedback, expanding catheter functionality beyond traditional mechanical roles. One of the most exciting advancements in catheter technology is pulse field ablation (PFA). This innovative energy modality uses ultra-short electrical pulses to selectively ablate cardiac tissue with reduced collateral damage compared with traditional thermal ablation techniques. PFA represents a paradigm shift in treating cardiac arrhythmias, offering improved safety profiles and greater procedural efficiency. Manufacturing PFA-enabled catheters demands multidisciplinary expertise to
www.medicaldevice-developments.com
integrate complex electronics, fine wiring and biocompatible materials – areas where Phillips Medisize’s combined design, assembly and manufacturing capabilities are uniquely suited to support innovation.
Market dynamics
The global demand for cardiovascular catheters continues to grow, driven by ageing populations, increased chronic cardiovascular conditions and expanding procedural indications. However, rising device complexity comes with heightened regulatory oversight worldwide. Compliance with FDA, CE and ISO standards requires stringent quality management systems and comprehensive documentation. Early, strategic engagement with regulatory authorities is essential. Phillips Medisize’s expertise in navigating these frameworks enables rapid product development cycles without compromising quality, helping bring innovations to market efficiently and confidently.
Design and engineering At the heart of cardiovascular catheter development lies a blend of material science, mechanical design and human factors engineering. Phillips Medisize leverages deep expertise in these areas to create catheters that can meet the demanding requirements of minimally invasive procedures – designing devices that can be flexible yet durable, biocompatible and engineered for precise navigation through complex vasculature. By utilising advanced polymers and user-centric design principles, it helps customers deliver catheters that can enhance procedural efficiency and patient safety.
Manufacturing challenges Precision manufacturing is foundational to cardiovascular catheter performance.
Micron-level tolerances and material integrity are critical; even slight deviations can impact clinical outcomes. The trend towards customised and patient-specific devices add complexity. Phillips Medisize’s state-of-the-art facilities employ precision injection moulding and advanced assembly technologies to produce high-quality catheters at scale. Its expertise extends to manufacturing medical connectors and cable assemblies – critical components that can ensure or support secure, reliable electrical connections within complex devices. Additionally, Temp-Flex fine wire assemblies and advanced termination capabilities provide customised, high- performance wiring solutions tailored to the demanding electrical and mechanical requirements of electrophysiology devices.
Collaboration and innovation as cornerstones
The future of cardiovascular catheters depends on sustained innovation, evolving regulatory frameworks and deep digital integration. Collaboration with developers, clinicians, manufacturers and regulators will be essential to overcoming challenges and accelerating the delivery of next- generation solutions. Pete Soupir, VP, medtech at Phillips Medisize, captures this collective vision: “Our mission is to empower healthcare innovation through precision engineering and manufacturing excellence. As connectivity becomes central to next-generation catheter technologies, it enables real-time data, smarter diagnostics and adaptive therapies – key factors driving technology adoption and advancing minimally invasive cardiovascular care. This integration is vital for unlocking new possibilities and improving patient outcomes worldwide.” ●
https://phillipsmedisize.com/medtech 39
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130
